1999
Recruitment in AIDS Clinical Trials: Investigation of Sociodemographic and Psychosocial Factors Affecting Participation in Clinical Research
Ethier K, Rodriguez M, Fox-Tierney R, Martin C, Friedland G, Ickovics J. Recruitment in AIDS Clinical Trials: Investigation of Sociodemographic and Psychosocial Factors Affecting Participation in Clinical Research. AIDS And Behavior 1999, 3: 219-230. DOI: 10.1023/a:1025456527845.Peer-Reviewed Original ResearchTrial participantsIDU historyClinical trialsAIDS clinical trialsGroup of HIVTrial regimenMedical therapyPsychosocial factorsHIV therapeuticsClinical researchTrial resultsTrialsBehavioral factorsHIVSociodemographic dimensionsPrimary objectiveParticipantsNonparticipantsRegimenPatientsTherapyMSMSociodemographicsRecruitmentPotential Sex Differences Remain Understudied: A Case Study of the Inclusion of Women in HIV/AIDS-Related Neuropsychological Research
Fox-Tierney R, Ickovics J, Cerreta C, Ethier K. Potential Sex Differences Remain Understudied: A Case Study of the Inclusion of Women in HIV/AIDS-Related Neuropsychological Research. Review Of General Psychology 1999, 3: 44-54. DOI: 10.1037/1089-2680.3.1.44.Peer-Reviewed Original ResearchSex differencesQuality of studiesHIV/AIDSPopulation of personsPotential sex differencesNeuropsychological manifestationsClinical researchMore womenWomenHIVNeuropsychological researchComprehensive literature reviewLiterature reviewInclusion of womenComplicationsReliable sex differencesStudyAIDSDifferences
1997
Adherence in AIDS clinical trials: A framework for clinical research and clinical care
Ickovics J, Meisler A. Adherence in AIDS clinical trials: A framework for clinical research and clinical care. Journal Of Clinical Epidemiology 1997, 50: 385-391. PMID: 9179096, DOI: 10.1016/s0895-4356(97)00041-3.Peer-Reviewed Original ResearchConceptsClinical trialsAIDS clinical trialsPoor medication adherenceAssessment of adherencePatient-provider relationshipClinical trial dataProtease inhibitor drugsTreatment regimenMedication adherenceMedical adherencePatient participationClinical careDrug failureTherapeutic outcomesViral resistanceNew treatmentsPatient careTrial dataTherapeutic valueClinical settingClinical interventionsClinical researchInhibitor drugsTrialsGood adherence